Reconnect Labs Raises CHF 22M to Develop AI-Based Mental Health Therapies
Reconnect Labs secures CHF 22M to develop AI-powered therapies for insomnia, anxiety, and mental health, with two candidates already in…
MoonLake Secures $500 Million for Future Therapies
MoonLake secures $500M non-dilutive funding to advance Sonelokimab, a nanobody therapy for inflammatory diseases, with launch targeted in 2027.
Isomorphic Labs Raises $600 Million to Advance AI-Driven Drug Discovery
Isomorphic Labs raises $600M to accelerate AI-driven drug discovery with AlphaFold 3 and prepare for first clinical trials.
Neuralink Opens Global Volunteer Recruitment: Mind-Controlled Computing Now Accessible Worldwide
Neuralink opens global recruitment for brain-chip trials. Paralysis patients worldwide can now apply. First success stories signal a new era…